Position
Chief Financial Officer
Company
Altimmune
MorristownBiotechnologyHealth CareTherapeuticsBiopharmaresearchDescription
Altimmune has appointed Greg Weaver, who brings over 25 years of finance experience in life sciences companies, as the new Chief Financial Officer.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Kesmalea Therapeutics Appoints Robert Johnson as Chief Executive Officer (November 7, 2024)
- Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024)
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Byondis Appoints Louis Denis, M.D. as Chief Medical Officer (November 19, 2024)
- BerGenBio Appoints Olav Hellebø as CEO (November 20, 2024)
Who to call at Altimmune, and when
A new leader at Altimmune brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Altimmune raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Altimmune, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Altimmune. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Altimmune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Altimmune changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.